New Radioactive Cancer Drug - Marilyn's Story - Nebraska Medicine
0 Views
administrator
07/09/23
On June 14, Marilyn Cody became the first Nebraska Medicine patient to receive Lutathera, a newly approved radioactive cancer drug, which is flown in from Italy. It’s used to treat a type of cancer that affects the pancreas or gastrointestinal tract, called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). To schedule an appointment with a Nebraska Medicine cancer specialist, call 402.559.5600.
Show more
Facebook Comments
No comments found